US Stock MarketDetailed Quotes

Krystal Biotech (KRYS)

Watchlist
  • 281.530
  • -7.595-2.63%
Close Jan 23 16:00 ET
  • 281.530
  • 0.0000.00%
Post 17:14 ET
8.16BMarket Cap42.21P/E (TTM)

Krystal Biotech (KRYS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-32.62%39.66M
1,365.09%52.73M
94.92%30.97M
238.98%123.42M
830.68%52.84M
377.29%58.86M
87.81%-4.17M
160.74%15.89M
11.70%-88.8M
67.61%-7.23M
Net income from continuing operations
192.00%79.36M
146.22%38.33M
3,734.01%35.73M
715.58%89.16M
423.23%45.48M
-66.34%27.18M
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
Operating gains losses
17.54%-1.29M
-67.31%-2.75M
-23.83%-1.5M
94.23%-6.07M
-36.15%-1.64M
98.46%-1.57M
-4.11%-1.65M
-49.94%-1.21M
-18,337.19%-105.09M
-103.72%-1.21M
Depreciation and amortization
5.43%1.61M
-23.65%1.54M
1.55%1.63M
13.58%6.71M
-11.50%1.56M
12.01%1.53M
36.74%2.02M
22.73%1.61M
74.62%5.91M
319.33%1.76M
Other non cash items
-146.38%-295K
-76.76%76K
357.98%614K
200.46%652K
-124.83%-73K
600.79%636K
567.35%327K
-23,900.00%-238K
538.24%217K
13.95%294K
Change In working capital
-253.20%-27.88M
101.48%494K
-394.16%-18.54M
62.47%-14.46M
78.25%-5.66M
291.78%18.2M
-181.74%-33.29M
-28.45%6.3M
-1,549.83%-38.52M
-4,356.16%-26.02M
-Change in receivables
-401.78%-17.92M
85.59%-8.18M
133.57%1.49M
-49.16%-62.71M
77.24%-7.45M
163.75%5.94M
---56.77M
---4.43M
---42.04M
---32.72M
-Change in inventory
-28.14%-4.71M
66.04%880K
37.67%-1.4M
-166.08%-11.91M
-1,225.41%-6.52M
-19.53%-3.68M
158.50%530K
---2.24M
---4.48M
---492K
-Change in prepaid assets
-9,290.98%-11.46M
100.83%19K
-1,303.77%-2.98M
-452.67%-8.91M
-447.39%-6.28M
-165.95%-122K
-338.05%-2.29M
-68.25%-212K
-162.11%-1.61M
30.26%-1.15M
-Change in payables and accrued expense
-62.59%6.02M
-71.59%7.06M
-219.97%-16.05M
556.31%68.48M
66.13%14.15M
419.03%16.1M
340.64%24.86M
46.29%13.38M
166.24%10.43M
598.77%8.52M
-Change in other current assets
----
----
----
----
----
88.61%-18K
-114.74%-23K
213.04%52K
----
----
-Change in other current liabilities
613.16%195K
86.88%712K
300.00%398K
170.69%586K
295.58%442K
82.96%-38K
277.21%381K
-20.61%-199K
-28.13%-829K
-20.21%-226K
Cash from discontinued investing activities
Operating cash flow
-32.62%39.66M
1,365.09%52.73M
94.92%30.97M
238.98%123.42M
830.68%52.84M
377.29%58.86M
87.81%-4.17M
160.74%15.89M
11.70%-88.8M
67.61%-7.23M
Investing cash flow
Cash flow from continuing investing activities
87.51%-4.29M
45.62%-10.53M
-110.81%-54.77M
-297.78%-163.44M
-724.59%-83.78M
-132.63%-34.33M
-21.28%-19.35M
-829.16%-25.98M
172.44%82.64M
-95.08%-10.16M
Net PPE purchase and sale
-62.91%-1.7M
-68.35%-1.9M
-392.38%-6.2M
64.08%-4.24M
56.63%-801K
41.27%-1.05M
59.46%-1.13M
76.58%-1.26M
77.73%-11.8M
64.60%-1.85M
Net investment purchase and sale
92.24%-2.58M
52.69%-8.62M
-98.22%-49M
-2,761.78%-159.2M
-898.16%-82.98M
-577.30%-33.28M
-38.39%-18.22M
-376.39%-24.72M
90.90%-5.56M
-92,466.67%-8.31M
Net other investing changes
--0
--0
--435K
----
----
----
----
----
--100M
--0
Cash from discontinued investing activities
Investing cash flow
87.51%-4.29M
45.62%-10.53M
-110.81%-54.77M
-297.78%-163.44M
-724.59%-83.78M
-132.63%-34.33M
-21.28%-19.35M
-829.16%-25.98M
172.44%82.64M
-95.08%-10.16M
Financing cash flow
Cash flow from continuing financing activities
10.22%3.71M
-83.12%1.8M
-217.79%-12.47M
-86.68%27.01M
-7.29%2.43M
-74.87%3.37M
-94.26%10.64M
617.98%10.58M
473.60%202.75M
-14.66%2.62M
Net common stock issuance
----
----
----
--0
--0
--0
----
----
451.01%159.73M
100.25%10K
Proceeds from stock option exercised by employees
10.37%3.71M
-83.12%1.8M
-90.84%1.46M
-25.98%32.4M
-6.94%2.43M
-75.09%3.37M
-58.17%10.64M
618.35%15.97M
524.61%43.77M
--2.61M
Net other financing activities
---5K
--0
-158.60%-13.93M
-619.09%-5.39M
--0
--0
--0
-619.09%-5.39M
-15.41%-749K
--0
Cash from discontinued financing activities
Financing cash flow
10.22%3.71M
-83.12%1.8M
-217.79%-12.47M
-86.68%27.01M
-7.29%2.43M
-74.87%3.37M
-94.26%10.64M
617.98%10.58M
473.60%202.75M
-14.66%2.62M
Net cash flow
Beginning cash position
2.33%353.83M
-13.99%308.77M
-3.76%344.87M
121.33%358.33M
0.19%373.97M
25.34%345.79M
155.08%359.01M
121.33%358.33M
-52.56%161.9M
100.23%373.24M
Current changes in cash
40.11%39.08M
441.54%44M
-7,486.15%-36.27M
-106.62%-13.01M
-92.97%-28.51M
-71.35%27.89M
-109.53%-12.88M
102.32%491K
209.64%196.58M
39.62%-14.77M
Effect of exchange rate changes
-207.34%-307K
414.24%1.06M
-8.56%171K
-193.59%-458K
-324.29%-594K
2,283.33%286K
-4,312.50%-337K
619.44%187K
-280.49%-156K
-241.46%-140K
End cash Position
4.98%392.6M
2.33%353.83M
-13.99%308.77M
-3.76%344.87M
-3.76%344.87M
0.19%373.97M
25.34%345.79M
155.08%359.01M
121.33%358.33M
121.33%358.33M
Free cash flow
-34.35%37.96M
1,059.14%50.83M
69.30%24.77M
218.47%119.18M
673.21%52.04M
351.28%57.81M
85.67%-5.3M
146.38%14.63M
34.48%-100.6M
67.04%-9.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -32.62%39.66M1,365.09%52.73M94.92%30.97M238.98%123.42M830.68%52.84M377.29%58.86M87.81%-4.17M160.74%15.89M11.70%-88.8M67.61%-7.23M
Net income from continuing operations 192.00%79.36M146.22%38.33M3,734.01%35.73M715.58%89.16M423.23%45.48M-66.34%27.18M146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M
Operating gains losses 17.54%-1.29M-67.31%-2.75M-23.83%-1.5M94.23%-6.07M-36.15%-1.64M98.46%-1.57M-4.11%-1.65M-49.94%-1.21M-18,337.19%-105.09M-103.72%-1.21M
Depreciation and amortization 5.43%1.61M-23.65%1.54M1.55%1.63M13.58%6.71M-11.50%1.56M12.01%1.53M36.74%2.02M22.73%1.61M74.62%5.91M319.33%1.76M
Other non cash items -146.38%-295K-76.76%76K357.98%614K200.46%652K-124.83%-73K600.79%636K567.35%327K-23,900.00%-238K538.24%217K13.95%294K
Change In working capital -253.20%-27.88M101.48%494K-394.16%-18.54M62.47%-14.46M78.25%-5.66M291.78%18.2M-181.74%-33.29M-28.45%6.3M-1,549.83%-38.52M-4,356.16%-26.02M
-Change in receivables -401.78%-17.92M85.59%-8.18M133.57%1.49M-49.16%-62.71M77.24%-7.45M163.75%5.94M---56.77M---4.43M---42.04M---32.72M
-Change in inventory -28.14%-4.71M66.04%880K37.67%-1.4M-166.08%-11.91M-1,225.41%-6.52M-19.53%-3.68M158.50%530K---2.24M---4.48M---492K
-Change in prepaid assets -9,290.98%-11.46M100.83%19K-1,303.77%-2.98M-452.67%-8.91M-447.39%-6.28M-165.95%-122K-338.05%-2.29M-68.25%-212K-162.11%-1.61M30.26%-1.15M
-Change in payables and accrued expense -62.59%6.02M-71.59%7.06M-219.97%-16.05M556.31%68.48M66.13%14.15M419.03%16.1M340.64%24.86M46.29%13.38M166.24%10.43M598.77%8.52M
-Change in other current assets --------------------88.61%-18K-114.74%-23K213.04%52K--------
-Change in other current liabilities 613.16%195K86.88%712K300.00%398K170.69%586K295.58%442K82.96%-38K277.21%381K-20.61%-199K-28.13%-829K-20.21%-226K
Cash from discontinued investing activities
Operating cash flow -32.62%39.66M1,365.09%52.73M94.92%30.97M238.98%123.42M830.68%52.84M377.29%58.86M87.81%-4.17M160.74%15.89M11.70%-88.8M67.61%-7.23M
Investing cash flow
Cash flow from continuing investing activities 87.51%-4.29M45.62%-10.53M-110.81%-54.77M-297.78%-163.44M-724.59%-83.78M-132.63%-34.33M-21.28%-19.35M-829.16%-25.98M172.44%82.64M-95.08%-10.16M
Net PPE purchase and sale -62.91%-1.7M-68.35%-1.9M-392.38%-6.2M64.08%-4.24M56.63%-801K41.27%-1.05M59.46%-1.13M76.58%-1.26M77.73%-11.8M64.60%-1.85M
Net investment purchase and sale 92.24%-2.58M52.69%-8.62M-98.22%-49M-2,761.78%-159.2M-898.16%-82.98M-577.30%-33.28M-38.39%-18.22M-376.39%-24.72M90.90%-5.56M-92,466.67%-8.31M
Net other investing changes --0--0--435K----------------------100M--0
Cash from discontinued investing activities
Investing cash flow 87.51%-4.29M45.62%-10.53M-110.81%-54.77M-297.78%-163.44M-724.59%-83.78M-132.63%-34.33M-21.28%-19.35M-829.16%-25.98M172.44%82.64M-95.08%-10.16M
Financing cash flow
Cash flow from continuing financing activities 10.22%3.71M-83.12%1.8M-217.79%-12.47M-86.68%27.01M-7.29%2.43M-74.87%3.37M-94.26%10.64M617.98%10.58M473.60%202.75M-14.66%2.62M
Net common stock issuance --------------0--0--0--------451.01%159.73M100.25%10K
Proceeds from stock option exercised by employees 10.37%3.71M-83.12%1.8M-90.84%1.46M-25.98%32.4M-6.94%2.43M-75.09%3.37M-58.17%10.64M618.35%15.97M524.61%43.77M--2.61M
Net other financing activities ---5K--0-158.60%-13.93M-619.09%-5.39M--0--0--0-619.09%-5.39M-15.41%-749K--0
Cash from discontinued financing activities
Financing cash flow 10.22%3.71M-83.12%1.8M-217.79%-12.47M-86.68%27.01M-7.29%2.43M-74.87%3.37M-94.26%10.64M617.98%10.58M473.60%202.75M-14.66%2.62M
Net cash flow
Beginning cash position 2.33%353.83M-13.99%308.77M-3.76%344.87M121.33%358.33M0.19%373.97M25.34%345.79M155.08%359.01M121.33%358.33M-52.56%161.9M100.23%373.24M
Current changes in cash 40.11%39.08M441.54%44M-7,486.15%-36.27M-106.62%-13.01M-92.97%-28.51M-71.35%27.89M-109.53%-12.88M102.32%491K209.64%196.58M39.62%-14.77M
Effect of exchange rate changes -207.34%-307K414.24%1.06M-8.56%171K-193.59%-458K-324.29%-594K2,283.33%286K-4,312.50%-337K619.44%187K-280.49%-156K-241.46%-140K
End cash Position 4.98%392.6M2.33%353.83M-13.99%308.77M-3.76%344.87M-3.76%344.87M0.19%373.97M25.34%345.79M155.08%359.01M121.33%358.33M121.33%358.33M
Free cash flow -34.35%37.96M1,059.14%50.83M69.30%24.77M218.47%119.18M673.21%52.04M351.28%57.81M85.67%-5.3M146.38%14.63M34.48%-100.6M67.04%-9.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More